Brookmont Capital Management - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Brookmont Capital Management ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2021$2,155,000
-10.8%
25,206
-1.5%
1.39%
-18.5%
Q4 2020$2,416,000
+3.3%
25,583
-4.9%
1.70%
-2.0%
Q3 2020$2,339,000
+1.8%
26,899
+2.2%
1.74%
-5.5%
Q2 2020$2,298,000
-14.4%
26,315
-19.2%
1.84%
-14.9%
Q1 2020$2,685,000
-19.3%
32,566
-7.4%
2.16%
+8.9%
Q4 2019$3,329,000
+0.1%
35,156
-8.2%
1.99%
+4.7%
Q3 2019$3,327,000
-21.4%
38,280
-17.5%
1.90%
-25.5%
Q2 2019$4,235,000
-4.3%
46,382
+0.8%
2.55%
-6.6%
Q1 2019$4,426,000
+12.2%
46,035
+0.1%
2.72%
+1.5%
Q4 2018$3,945,000
+17.2%
45,976
+17.6%
2.68%
+33.8%
Q3 2018$3,367,000
+13.6%
39,082
-0.4%
2.01%
+7.6%
Q2 2018$2,965,000
-5.8%
39,246
+0.9%
1.86%
-10.4%
Q1 2018$3,146,000
-55.5%
38,912
-53.8%
2.08%
-31.8%
Q4 2017$7,074,000
+48.6%
84,252
+52.0%
3.05%
+17.0%
Q3 2017$4,759,000
-45.0%
55,430
-46.5%
2.61%
-20.2%
Q2 2017$8,655,000
+8.4%
103,689
-3.5%
3.26%
+10.5%
Q1 2017$7,984,000
+0.7%
107,495
-1.2%
2.95%
-5.4%
Q4 2016$7,925,000
-15.4%
108,795
-8.3%
3.12%
-10.6%
Q3 2016$9,370,000
-3.7%
118,664
+0.6%
3.49%
-1.5%
Q2 2016$9,733,000
-4.6%
117,962
-16.3%
3.54%
+8.4%
Q1 2016$10,206,000
-15.9%
140,888
-0.1%
3.27%
-5.2%
Q4 2015$12,138,000
-8.5%
141,076
-2.2%
3.45%
-9.0%
Q3 2015$13,261,000
-13.7%
144,265
-7.7%
3.79%
-2.5%
Q2 2015$15,372,000
-0.7%
156,313
-0.4%
3.89%
+0.4%
Q1 2015$15,477,000
+17.1%
156,954
+10.0%
3.88%
+1.5%
Q4 2014$13,216,000
-16.3%
142,630
-15.0%
3.82%
-5.4%
Q3 2014$15,786,000
-2.3%
167,703
-6.0%
4.04%
+3.7%
Q2 2014$16,158,000
+17.6%
178,479
+10.5%
3.89%
+3.2%
Q1 2014$13,738,000
+4.1%
161,580
-1.6%
3.78%
+3.7%
Q4 2013$13,199,000
+24.8%
164,213
+19.1%
3.64%
+5.7%
Q3 2013$10,580,000
+79.7%
137,924
+65.7%
3.44%
+41.2%
Q2 2013$5,886,00083,2382.44%
Other shareholders
NOVARTIS A G shareholders Q2 2019
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders